BioGraph 55, Inc.

📍 San Francisco, United States🗓 Founded 2016👥 6 employees
Biotechnology🌐 biograph55.com
Website LinkedIn
BioGraph 55, Inc. is a San Francisco based early-stage target discovery and drug development biotech company focused on immuno-oncology. The company leverages a proprietary and scientifically validated (through external partners) spatial-mapping technology platform called SPARTA (Spatial Processing And Regional Tissue Analysis) that collects biological information from cellular interactions and integrates this information with genomic/transcriptomic data to identify novel drug targets. Our first program aims to develop an antibody therapy that: i) targets ~ 30-50% of nonresponsive, "hot"​ tumors, ii) targets a largely unexplored cell regulator of tumor immunity and iii) works by removing local immunosuppression from "hot"​ tumors.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was BioGraph 55, Inc. founded?
BioGraph 55, Inc. was founded in 2016.
What industry is BioGraph 55, Inc. in?
BioGraph 55, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is BioGraph 55, Inc. based?
BioGraph 55, Inc. is headquartered in San Francisco, United States.